Our findings indicate that deleterious NOD2 variants should be considered as strong predictors of IBD-CD onset and implicate NOD2 as a Mendelian disease gene for early onset IBD, specifically for a molecularly defined subset of Crohn’s disease patients. This evidence concerns the gene NOD2 and Crohn disease.